Teen Longitudinal Assessment of Bariatric Surgery (Teen LABS) Research Project
Project Number7UM1DK072493-17
Former Number5UM1DK072493-16
Contact PI/Project LeaderINGE, THOMAS HARRIS
Awardee OrganizationLURIE CHILDREN'S HOSPITAL OF CHICAGO
Description
Abstract Text
Abstract
This application requests renewal of the current grant supporting the five clinical centers that
comprise the Teen-LABS (TL) consortium. This multicenter, prospective, observational study of
the risks and benefits bariatric surgery successfully recruited 242 consecutive adolescents
undergoing bariatric surgery at participating clinical centers and has retained these subjects for
long-term follow up. By the end of the current funding period (August 2016), most will have
completed 5 years of follow-up. A renewal of funding will provide an opportunity to examine long-
term outcomes of Roux en Y gastric bypass and sleeve gastrectomy, the most commonly used
operations today. Collection of additional longitudinal measures from years 6 to10 will importantly
document durability of weight loss and comorbidity resolution, quality of life, micronutrient status,
and will identify long-term adverse events. Continued collection of biospecimens will continue to
drive new discovery by investigators utilizing the ancillary studies mechanism. Addition of new
measures to study bone health, cognitive function, and behavioral patterns will further enhance
the value of an extension of the study.
Public Health Relevance Statement
Project Narrative
Severe obesity affects nearly 4.5 million children and adolescents, threatening their current and
future health. Non-surgical treatments for severe pediatric obesity are not effective. Weight
loss surgery holds promise as an effective and durable treatment option for reversal of severe
obesity and reversal of obesity related comorbid conditions. The Teen-LABS study will
document the long term beneficial treatment effects and adverse outcomes of weight loss
surgery used in adolescence.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
074438755
UEI
XJ7MMPHBMGM7
Project Start Date
23-September-2011
Project End Date
30-June-2024
Budget Start Date
06-April-2022
Budget End Date
30-June-2024
Project Funding Information for 2020
Total Funding
$1,170,777
Direct Costs
$2,410,033
Indirect Costs
$554,342
Year
Funding IC
FY Total Cost by IC
2020
National Institute of Diabetes and Digestive and Kidney Diseases
$1,170,777
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7UM1DK072493-17
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7UM1DK072493-17
Patents
No Patents information available for 7UM1DK072493-17
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7UM1DK072493-17
Clinical Studies
No Clinical Studies information available for 7UM1DK072493-17
News and More
Related News Releases
No news release information available for 7UM1DK072493-17
History
No Historical information available for 7UM1DK072493-17
Similar Projects
No Similar Projects information available for 7UM1DK072493-17